Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease
血浆pTau217作为路易体病临床进展的预后、监测和风险分层生物标志物
期刊:
影响因子:
doi:10.64898/2026.03.26.26349399
Lorkiewicz, S A; Abdelnour, C; Bolen, M; Smith, A M; Shahid-Besanti, M; Hemachandra, D; Müller-Oehring, E M; Siddiqui, N; Montoliu-Gaya, L; Arslan, B; Ashton, N J; Wilson, E N; Tian, L; Andreasson, K I; Mormino, E C; Henderson, V W; Zetterberg, H; Poston, K L